Sign Up to like & get
recommendations!
1
Published in 2018 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2018-rcpch.224
Abstract: Aim Insulin pump therapy i.e. Continuous Subcutaneous Insulin Infusion therapy (CSII) is a well-recognised treatment modality in Type 1 Diabetes Mellitus (T1DM). NICE recommends a target%HbA1c level ≤6.5% to minimise long-term complication risk1. CSII can be…
read more here.
Keywords:
patients managed;
hba1c;
diabetes control;
csii ... See more keywords